FRI-497-Shifting to sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: A real world experience.
Saved in:
| Title: | FRI-497-Shifting to sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: A real world experience. |
|---|---|
| Authors: | Po-Ting, Lin, Jeng, RachelWen-Juei, Hsieh, Yi-Chung, Teng, Wei, Hung, Chen-Fu, Huang, Chien-Hao, Lui, Kar-Wai, Chen, Yi-Cheng, Lin, Chen-Chun, Lin, Chun-Yen, Lin, Shi-Ming, Sheen, I-Shyan |
| Source: | Journal of Hepatology. Apr2019 Supplement, Vol. 70, pe618-e618. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 136346102 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FRI-497-Shifting to sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: A real world experience. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Po-Ting%2C+Lin%22">Po-Ting, Lin</searchLink><br /><searchLink fieldCode="AR" term="%22Jeng%2C+RachelWen-Juei%22">Jeng, RachelWen-Juei</searchLink><br /><searchLink fieldCode="AR" term="%22Hsieh%2C+Yi-Chung%22">Hsieh, Yi-Chung</searchLink><br /><searchLink fieldCode="AR" term="%22Teng%2C+Wei%22">Teng, Wei</searchLink><br /><searchLink fieldCode="AR" term="%22Hung%2C+Chen-Fu%22">Hung, Chen-Fu</searchLink><br /><searchLink fieldCode="AR" term="%22Huang%2C+Chien-Hao%22">Huang, Chien-Hao</searchLink><br /><searchLink fieldCode="AR" term="%22Lui%2C+Kar-Wai%22">Lui, Kar-Wai</searchLink><br /><searchLink fieldCode="AR" term="%22Chen%2C+Yi-Cheng%22">Chen, Yi-Cheng</searchLink><br /><searchLink fieldCode="AR" term="%22Lin%2C+Chen-Chun%22">Lin, Chen-Chun</searchLink><br /><searchLink fieldCode="AR" term="%22Lin%2C+Chun-Yen%22">Lin, Chun-Yen</searchLink><br /><searchLink fieldCode="AR" term="%22Lin%2C+Shi-Ming%22">Lin, Shi-Ming</searchLink><br /><searchLink fieldCode="AR" term="%22Sheen%2C+I-Shyan%22">Sheen, I-Shyan</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Hepatology%22">Journal of Hepatology</searchLink>. Apr2019 Supplement, Vol. 70, pe618-e618. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=136346102 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0618-8278(19)31232-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: e618 Titles: – TitleFull: FRI-497-Shifting to sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: A real world experience. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Po-Ting, Lin – PersonEntity: Name: NameFull: Jeng, RachelWen-Juei – PersonEntity: Name: NameFull: Hsieh, Yi-Chung – PersonEntity: Name: NameFull: Teng, Wei – PersonEntity: Name: NameFull: Hung, Chen-Fu – PersonEntity: Name: NameFull: Huang, Chien-Hao – PersonEntity: Name: NameFull: Lui, Kar-Wai – PersonEntity: Name: NameFull: Chen, Yi-Cheng – PersonEntity: Name: NameFull: Lin, Chen-Chun – PersonEntity: Name: NameFull: Lin, Chun-Yen – PersonEntity: Name: NameFull: Lin, Shi-Ming – PersonEntity: Name: NameFull: Sheen, I-Shyan IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 04 Text: Apr2019 Supplement Type: published Y: 2019 Identifiers: – Type: issn-print Value: 01688278 Numbering: – Type: volume Value: 70 Titles: – TitleFull: Journal of Hepatology Type: main |
| ResultId | 1 |
